Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence of disease stabilization or improvement after a one-time…
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence of disease stabilization or improvement after a one-time…
85% of global enterprises are actively using or testing generative AI in at least one function SAN FRANCISCO, Nov. 14,…
SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- 2024 marks the eleventh year since the establishment of the SANY Foundation. The foundation's inaugural…
SINGAPORE, Nov. 5, 2024 /PRNewswire/ -- HTX Ventures, the global investment division of HTX, today unveils its latest research on…